Page last updated: 2024-11-01

nilvadipine and Hypertension, Renal

nilvadipine has been researched along with Hypertension, Renal in 2 studies

Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.

Research Excerpts

ExcerptRelevanceReference
" No tolerance to the antihypertensive effect of KRN4884 was observed during a 15-day repeated dosing period."1.30KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs. ( Endo, M; Izawa, T; Izumi, H; Jinno, Y; Kawahara, J; Takeuchi, A, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawahara, J1
Jinno, Y1
Endo, M1
Izumi, H1
Takeuchi, A1
Izawa, T1
Ohtsuka, M1
Koibuchi, Y1
Sakai, S1
Tsujioka, K1
Fujiwara, T1
Ozaki, T1
Maeda, K1
Motoyama, I1
Horiai, H1
Ono, T1

Other Studies

2 other studies available for nilvadipine and Hypertension, Renal

ArticleYear
KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:6

    Topics: Animals; Antihypertensive Agents; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; H

1997
Effects of nilvadipine on the cardiovascular system in experimental animals.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:11

    Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Dogs; Female; Guinea

1988